| 1 |
[177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results |
|
|
| Madhav Prasad Yadav,Sanjana Ballal,Marian Meckel,Frank Roesch,Chandrasekhar Bal |
|
| EJNMMI Research. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain |
|
|
| Reyhaneh Manafi-Farid,Fardad Masoumi,Ghasemali Divband,Bahare Saidi,Bahar Ataeinia,Fabian Hertel,Gregor Schweighofer-Zwink,Agnieszka Morgenroth,Mohsen Beheshti |
|
| Journal of Clinical Medicine. 2020; 9(8): 2622 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-analysis |
|
|
| Emran Askari,Sara Harsini,Nasim Vahidfar,Ghasemali Divband,Ramin Sadeghi |
|
| Cancer Biotherapy and Radiopharmaceuticals. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on ß-Emitting and a-Emitting Radionuclides |
|
|
| Alireza Sadremomtaz,Mahboubeh Masoumi |
|
| Journal of Medical Imaging and Radiation Sciences. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results |
|
|
| Ambreen Khawar,Elisabeth Eppard,Frank Roesch,Hojjat Ahmadzadehfar,Stefan Kürpig,Michael Meisenheimer,Florian. C. Gaertner,Markus Essler,Ralph. A. Bundschuh |
|
| EJNMMI Research. 2019; 9(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Analgesia and curative effect of pamidronate disodium combined with chemotherapy on elderly patients with advanced metastatic bone cancer |
|
|
| Jiayong Liu,Chaoqian Zhao,Bin Liu,Hua Liu,Lixin Wang |
|
| Oncology Letters. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases |
|
|
| Ambreen Khawar,Elisabeth Eppard,Frank Roesch,Hojjat Ahmadzadehfar,Stefan Kürpig,Michael Meisenheimer,Florian. C. Gaertner,Markus Essler,Ralph. A. Bundschuh |
|
| Annals of Nuclear Medicine. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
177Lu/153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone Metastases |
|
|
| Mehrosadat Alavi,Farnaz Khajeh-Rahimi,Hassan Yousefnia,Mohammad Mohammadianpanah,Samaneh Zolghadri,Ali Bahrami-Samani,Mohammad Ghannadi-Maragheh |
|
| Cancer Biotherapy and Radiopharmaceuticals. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Radionuclide Therapy for Bone Metastases |
|
|
| Hojjat Ahmadzadehfar,Markus Essler,Kambiz Rahbar,Ali Afshar-Oromieh |
|
| PET Clinics. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy |
|
|
| Ana M Denis-Bacelar,Sarah J Chittenden,V Ralph McCready,Antigoni Divoli,David P Dearnaley,Joe M O’Sullivan,Bernadette Johnson,Glenn D Flux |
|
| The British Journal of Radiology. 2018; : 20170795 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran |
|
|
| Amir Reza Jalilian,Davood Beiki,Arman Hassanzadeh-Rad,Arash Eftekhari,Parham Geramifar,Mohammad Eftekhari |
|
| Seminars in Nuclear Medicine. 2016; 46(4): 340 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases |
|
|
| Rogier Lange,Rob ter Heine,Russ (FF) Knapp,John M.H. de Klerk,Haiko J. Bloemendal,N. Harry Hendrikse |
|
| Bone. 2016; 91: 159 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Estimated human absorbed dose of 177Lu–BPAMD based on mice data: Comparison with 177Lu–EDTMP |
|
|
| Hassan Yousefnia,Samaneh Zolghadri,Saeed Shanehsazzadeh |
|
| Applied Radiation and Isotopes. 2015; 104: 128 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
Users Online: 157 
